Latest Breaking News On - International liver - Page 3 : comparemela.com

World Hepatitis Day 2022: I can t wait theme stresses importance of testing, treatment

World Hepatitis Day 2022: I can t wait theme stresses importance of testing, treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoBaruch blumbergGeorg semmlerChristiana grafPhilippa easterbrookBeatrice emmanouilSarah blachDanielq huangHeiner wedemeyerBykate burbaUniversity of californiaNational centerHannover medical schoolResearch centerUniversity hospital frankfurt department

Bulevirtide Beneficial in Hepatitis D: Phase 3 Data

“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”

United statesThomas bergNordrhein westfalenFrance generalCity ofUnited kingdomHeiner wedemeyerGilead sciencesHannover germany medical schoolBordeaux france university hospitalMedscape professional networkUniversity clinic leipzig germanyInternational liver congressInternational liverEuropean associationSecretary general

Liver transplantation linked to lower antibody, T-cell response to COVID-19 vaccine

LONDON — Patients who received a liver transplant had significantly reduced antibody and T-cell responses to SARS-CoV-2 vaccination compared with healthy controls, according to research presented at the International Liver Congress.

United kingdomCity ofKate burbaThomas marjotOxford liver unit at university hospitalsInternational liver congressInternational liverOxford liver unitOxford university hospitals

Madrigal Pharma (MDGL) Reports Late-Breaking Phase 3 NASH Data

Madrigal Pharma (MDGL) Reports Late-Breaking Phase 3 NASH Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesCity ofUnited kingdomPaul friedmanBecky taubContactschristopher fratesStephen harrisonAlex howarthRegistration program for the treatmentResearch development of madrigalMadrigal pharmaceuticalsMadrigal pharmaceuticals incExchange commissionPinnacle clinical researchOxford university

DAA use decreases risk for cardiovascular events in patients with advanced fibrosis, HCV

LONDON — Direct-acting antiviral treatment correlated with a decreased risk for cardiovascular outcomes among patients with hepatitis C virus and advanced fibrosis but an increased risk for arrhythmias and conduction disorders. “Several studies have revealed that hepatitis C virus can induce chronic inflammation and immune dysregulation, and this immune dysregulation and chronic

France generalCity ofUnited kingdomKate burbaPublic health at sorbonne universityFrench national health insurance databasePierre louis institute of epidemiologyInternational liver congressPierre louis institutePublic healthSorbonne universityInternational liver